H.C. Wainwright Downgrades AMAG Pharmaceuticals (AMAG) to Neutral
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 20
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 20
Trade Now!
Join SI Premium – FREE
H.C. Wainwright analyst Douglas Tsao downgraded AMAG Pharmaceuticals (NASDAQ: AMAG) from Buy to Neutral with a price target of $13.75.
For an analyst ratings summary and ratings history on AMAG Pharmaceuticals click here. For more ratings news on AMAG Pharmaceuticals click here.
Shares of AMAG Pharmaceuticals closed at $13.61 yesterday.
You May Also Be Interested In
- Macquarie Downgrades NRW Holdings Ltd. (NWH:AU) to Neutral
- Goldman Sachs Downgrades Zalando SE (ZAL:GR) (ZLNDY) to Conviction Buy
- UPDATE: Baxter International (BAX) PT Lowered to $71 at Wells Fargo, Downgrades to Equalweight (correction)
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
